Bioprogress is a stock I have been in and out of quite a few times since it floated in May but not much mention here on the Investors' Room. Does anyone else follow this stock. I see it is up 1.5p today and a few good buyers seem to have appeared.

Another none event.

Strange share this one, happy to be in but it is a definite rollercoaster ride at the moment. Maybe upward once the Amercian market open...

Very odd.. SEO down 11.11% yet BPRG only up 1.72%?

Hmm, well they do say shares fall faster than they rise!

We shall see what the American market makes of this.... Still at least were up at present...

Is this a pairs trade, G?

;-0

Yeah I wish ;)

It's moving the right direction WOW!

;-)

http://www.moneyam.com/action/news/showArticle?id=497256

It just gets messier and messier.

As far as I read it, both will eventually pay some costs so they're both down on it.

Big Al, that afx is confused.. if you read both RNS carefully it is a different picture to that

3 November 2004



Stanelco plc

Clarification of Patent Entitlement Case

Stanelco finds it necessary to clarify certain information contained
within one
of BioProgress' press releases in connection with the litigation
between the two
companies.


Stanelco wishes to clarify that the Court has not ordered that
Stanelco has to
pay damages to BioProgress. No final Order will be made until Stanelco's
application to admit further evidence, which may result in a
reconsideration of
certain of the Judge's findings, has been determined. All the Court has
determined to date are the principles of a mechanism through which any
damages
will be assessed, if a final Order for damages is ultimately made.


It is Stanelco's firm position that no damages, or at worst, minimal
damages,
will ultimately be found to be payable to BioProgress.


BioProgress PLC
03 November 2004


Press Release 3 November 2004


BioProgress plc

("BioProgress" or "the Company")

Further success for BioProgress in patent entitlement case


BioProgress plc (AIM: BPRG; NASDAQ: BPRG) announces that in a hearing
yesterday
in the dispute between BioProgress Technology Limited and Stanelco
Fibre Optics
Limited ("Stanelco"), the UK Patents Court made further rulings
following the
previous judgment handed down on 1 October 2004.


The Court made various declarations about which company had invented
the process
of sealing water-soluble polymeric materials by radio frequency ("RF")
welding
in order to form capsules. These declarations made reference to
BioProgress'
sole entitlement to the main claim and all except three subsidiary
claims in the
Master Patent. The Court also clarified that BioProgress' entitlement
to the
main patent claims in the Master Patent conferred no right upon
Stanelco to use
any of the subsidiary processes without the permission of BioProgress.


In its earlier judgment, the Court had held that Stanelco had misused
Bioprogress' confidential information by making the patent filings
which founded
the three families of patents. Yesterday, the Court made an Order for
the
commencement of the procedure for assessing the amount to be paid in
damages by
Stanelco to BioProgress for breach of confidence.


Stanelco was ordered to disclose details of its foreign patent
applications, so
that ownership of all patents and patent applications in the Master
Patent
family can be dealt with at a further, final hearing in approximately
4-6 weeks
time.


The Court also made an order for costs in favour of BioProgress.
Stanelco must
make an interim payment towards these costs of approximately
GBP180,000 within two
weeks.


At the end of the hearing, Stanelco indicated that it had commenced an
application to request the Court to reconsider certain aspects of the
previous
judgment. Stanelco was ordered to file its evidence within seven days.


Graham Hind, Chief Executive of BioProgress said: "We are very pleased
that the
Court has confirmed our entitlement to the main patent claims in the
Master
Patent and has awarded us interim costs. The Court has made clear
directives to
Stanelco as to the course of action it must now take. We remain as
comfortable
as we have always been with our position, and will be making no
further comment
until the next hearing is concluded."


- Ends -

They've banned me from their thread on ADVFN free bb.

Tw*ts :-)

G - I always read these things too quick and I ain't the best interpreter at times. ;-)

Dil - surprised you lasted so long m8! LOL

Me too :-)

What the hell is going on, someone must get reported to the FSA for this total and utter bollo..s. You can't just put these RNS's out without any substance, can anyone who was at the case throw some light on this. We shareholders cannot be treated like this...

AdieH: BPRG have a very strong legal case, indeed they have won the argument. However the defending companies lawyers are using all available legal means to change the outcome. This is a natural process. The Judge has given them time to come back to CC with a fully detailed challenge concerning overseas patents. These things take time but we are in the closing stretch and it will, IMO, all be over before XMAS and the judgement will all be BPRG's favour.

Be patient on this as it does sound confusing, and of course to shareholders hoping for a quick and clinical outcome it is very frustrating, but it will all end soon.

So I suggest you follow the BPRG RNS posting. You can of course complain to the FSA but by the time they get around to investigating it will be all over...or I have got this completely wrong!!

Thanks, I hold on for big profits in the future, I hope, but it seems to be me that SEO are clutching at straws and there shareholders should be asking questions of their board... Thought about investing in SEO once case over with but this has certainly made me very wary...

AdieH

IMO, as a long term investor, you should be concentrating on the fundamentals going forward and not some piss-arse case, the shenanigans of which should be of no concern. At the end of the day it will not impact massively on what happens 2,3,4,5 years hence, which I assume is your ultimate goal. I really can't see what you're getting all hot and bothered about. I thought all the nutters were on ADVFN!!

Chill out and watch your investment grow, if it can and if it does.

Al
;-)

Big Al - I know Bio have played it down but this case potentially has a large effect going forward as it concerns the Swallo technology which Wyeth are interested in. Ingel (the Stanelco JV with Cardinal Health) is directly affected. Wyeth is Cardinal's biggest customer and Ingel is/was in competition with BPRG potentially.

Can anyone give me a reason for the SEO RNS, the purpose of which:

"Stanelco finds it necessary to clarify certain information contained
within one
of BioProgress' press releases in connection with the litigation
between the two
companies.
Stanelco wishes to clarify that the Court has not ordered that
Stanelco has to
pay damages to BioProgress."



i.e., where did BPRG state that BRPG had mentioned the payment of damages? They are yet to be resolved, it is the interim costs and some of them have to be paid within 14 days!

Bones , its a side show that traders will feed on. As Al says , has little relevance on long term prospects.

GBP xxxx settlement for or against is irrelevant for "a FTSE100 Company Of The Future"...... yeah right :-)

We need to have a chat sometime to clear the air Bones , I'm not a deramper I invest on fundamentals but these have no track record or alternitivley I trade on chart signals (these are a neutral at best).